Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
GSK’s Bexsero Dangles No More: Meningococcal B Vaccine Converts To Regular Approval
Aug 23 2024
•
By
Sue Sutter
There is one less "dangling" accelerated approval now that GSK's Bexsero has converted. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Vaccines
More from Pink Sheet